Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis

Evidence of the effectiveness of B-cell-depleting monoclonal antibodies (mAbs) in multiple sclerosis (MS) prompted a partial revisitation of the pathogenetic paradigm of the disease, which was, so far, considered a T-cell-mediated autoimmune disorder. Mechanisms underlying the efficacy of B-cell-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Massacesi, Luca, Mariottini, Alice, Nicoletti, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332715/
https://www.ncbi.nlm.nih.gov/pubmed/35893382
http://dx.doi.org/10.3390/jcm11154288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332715/
https://www.ncbi.nlm.nih.gov/pubmed/35893382
http://dx.doi.org/10.3390/jcm11154288

Ejemplares similares